- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT07389018
Prospektivt Longitudinalt Monocentrisk Studie til Vurdering af Gennemførligheden af Syde® Digitale Endepunkter til Overvågning af Patienter med Progressiv Supranukleær Parese - Richardson Syndrom (PSP-R) (PROSPER-SYDE)
Prospektivt longitudinelt monocentrisk studie til evaluering af gennemførligheden af Syde® digitale endpoints til monitorering af patienter med progressiv supranuklear parese - Richardson syndrom (PSP-R)
The study aims to assess the feasibility/acceptability of real-world activity monitoring by the Syde® wearable device in PSP-R. The Syde® collected data will be compared to on-site conventional clinical endpoints, including functional capacity and cognitive assessments, as well as core scales assessments.
Studieoversigt
Status
Undersøgelsestype
Tilmelding (Anslået)
Kontakter og lokationer
Studiekontakt
- Navn: Ferial Toumi
- Telefonnummer: +33 2 78 00 10 98
- E-mail: ferial.toumi@sysnav.fr
Studiesteder
-
-
-
Paris, Frankrig, 75019
- Hôpital Fondation Adolphe de Rothschild
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Prøveudtagningsmetode
Studiebefolkning
Patients With Progressive Supranuclear Palsy - Richardson Syndrome (PSP-R)
Beskrivelse
Inclusion Criteria:
1.18 years old or older
2.Participants affiliated to, or beneficiary from, a social security.
3.Ambulant patients (i.e. able to walk 10 meters without assistance)
4.Signed informed consent form by the patient himself or, by caregivers if the patient is not capable to fill, date and sign the form due to fine motor function difficulties..
5.Possible or probable PSP-R according to MDS criteria 2017(Hoglinger et al., Mov Disorder, 2017).
Exclusion Criteria:
- Patients with extreme cognitive disorders that limit their understanding of the data collection process (training of device use and 4-week recording periods every 4 months, device return at the end of the study), tests to be performed including eye movement recording (every 8 months), the implication of the study and consent.
- Patients who do not tolerate to keep the sensors on their ankles.
- Patients who have undergone a surgical procedure or who have experienced recent trauma (within fewer than 6 months) affecting the lower limbs.
- A concomitant chronic or acute neurological, endocrine, infectious, allergic, or inflammatory pathology within the 3-week period immediately prior to inclusion.
- Patients affected by any other disorder having a significant impact on gait or lower limb function.
- Participant covered by a legal protection measure (guardianship, curatorship or safeguarding of justice) or who is unable to express their consent.
- Absence of caregiver.
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Observationsmodeller: COHORT
- Tidsperspektiver: PROSPECTIVE
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Number of patients reaching the optimal threshold of recordings during the recording periods defined in the protocol.
Tidsramme: 16 months
|
Number of patients reaching the optimal threshold of recordings during the recording periods defined in the protocol (supposed optimal threshold for analysis) at baseline, Month 4, Month 8, Month 12 and Month 16. |
16 months
|
|
French Usability score (F-SUS) at Month 4 and at the end of the study
Tidsramme: 16 months
|
Usability score at Month 4 and Month 16. The System Usability Scale is a 10-item questionnaire . It is a simple tool to measure the usability of an interactive system and it is widely used. For each item, the user is asked to express their level of agreement or disagreement from 1 (strongly disagree) and 5 (strongly agree). |
16 months
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Change from baseline in the total wearing time at months 4, 8, 12, and 16.
Tidsramme: 16 months
|
Change from baseline in the total wearing time at months 4, 8, 12, and 16. |
16 months
|
|
Reproducibility of Syde® digital endpoints for each recording period timepoint
Tidsramme: 16 months
|
Reproducibility of Syde® digital endpoints assessed by the ICC (Intra-Class Correlation) and Bland and Altman analysis for each recording period timepoint (baseline, 4 months, 8 months, 12 months, and 16 months) |
16 months
|
|
Correlation between Syde® digital endpoints and 2-minute walk test (2MWT)
Tidsramme: 16 months
|
Correlation at baseline and at different timepoints between Syde® digital endpoints and 2MWT |
16 months
|
|
Correlation between Syde® digital endpoints and 10-meter walk test (10MWT)
Tidsramme: 16 months
|
Correlation at baseline and at different timepoints between Syde® digital endpoints and 10MWT |
16 months
|
|
Correlation between Syde® digital endpoints and Timed Up and Go (TUG)
Tidsramme: 16 months
|
Correlation at baseline and at different timepoints between Syde® digital endpoints and TUG |
16 months
|
|
Correlation between Syde® digital endpoints and falls reported by the participants
Tidsramme: 16 months
|
Correlation at baseline and at different timepoints between Syde® digital endpoints and falls reported by the participants |
16 months
|
|
Correlation between Syde® digital endpoints and Progressive Supranuclear Palsy Rating Scale (PSP-RS)
Tidsramme: 16 months
|
Correlation at baseline and at different timepoints between Syde® digital endpoints and PSP-RS |
16 months
|
|
Correlation between Syde® digital endpoints and Progressive Supranuclear Palsy Clinical Deficits Scale (PSP-CDS)
Tidsramme: 16 months
|
Correlation at baseline and at different timepoints between Syde® digital endpoints and PSP-CDS |
16 months
|
|
Correlation between Syde® digital endpoints and Montreal Cognitive Assessment (MoCA)
Tidsramme: 16 months
|
Correlation at baseline and at different timepoints between Syde® digital endpoints and MoCA |
16 months
|
|
Longitudinal change in Syde® digital endpoints. The Syde® digital endpoints will include the SV95C (Stride Velocity 95th centile)
Tidsramme: 16 months
|
Change from baseline in Syde® digital endpoints at 4, 8, 12 and 16 months. The Syde® digital endpoints will include the SV95C (Stride Velocity 95th centile) |
16 months
|
Samarbejdspartnere og efterforskere
Sponsor
Efterforskere
- Ledende efterforsker: Jean-Philippe BRANDEL, Hopital Fondation Adolphe de Rothschild
Datoer for undersøgelser
Studer store datoer
Studiestart (Anslået)
Primær færdiggørelse (Anslået)
Studieafslutning (Anslået)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Andre undersøgelses-id-numre
- PR5030-76
- 2024-A02611-46 (Anden identifikator: ANSM)
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .